vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Xponential Fitness, Inc. (XPOF). Click either name above to swap in a different company.

Xponential Fitness, Inc. is the larger business by last-quarter revenue ($83.0M vs $47.7M, roughly 1.7× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -39.6%, a 34.8% gap on every dollar of revenue. On growth, Xponential Fitness, Inc. posted the faster year-over-year revenue change (-0.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $10.2M). Over the past eight quarters, Xponential Fitness, Inc.'s revenue compounded faster (2.0% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Xponential Fitness is one of the largest global franchisor of fitness boutiques. Its franchises operate in 49 U.S. states and 31 countries with more than 3,000 studios open. The company is headquartered in Irvine, California.

IRWD vs XPOF — Head-to-Head

Bigger by revenue
XPOF
XPOF
1.7× larger
XPOF
$83.0M
$47.7M
IRWD
Growing faster (revenue YoY)
XPOF
XPOF
+47.0% gap
XPOF
-0.3%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
34.8% more per $
IRWD
-4.8%
-39.6%
XPOF
More free cash flow
IRWD
IRWD
$64.4M more FCF
IRWD
$74.6M
$10.2M
XPOF
Faster 2-yr revenue CAGR
XPOF
XPOF
Annualised
XPOF
2.0%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
XPOF
XPOF
Revenue
$47.7M
$83.0M
Net Profit
$-2.3M
$-32.9M
Gross Margin
Operating Margin
14.3%
-9.9%
Net Margin
-4.8%
-39.6%
Revenue YoY
-47.3%
-0.3%
Net Profit YoY
-200.9%
24.4%
EPS (diluted)
$0.01
$-1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
XPOF
XPOF
Q4 25
$47.7M
$83.0M
Q3 25
$122.1M
$78.8M
Q2 25
$85.2M
$76.2M
Q1 25
$41.1M
$76.9M
Q4 24
$90.5M
$83.2M
Q3 24
$91.6M
$80.5M
Q2 24
$94.4M
$76.9M
Q1 24
$74.9M
$79.7M
Net Profit
IRWD
IRWD
XPOF
XPOF
Q4 25
$-2.3M
$-32.9M
Q3 25
$40.1M
$-4.9M
Q2 25
$23.6M
$969.0K
Q1 25
$-37.4M
$-1.9M
Q4 24
$2.3M
$-43.5M
Q3 24
$3.6M
$-12.1M
Q2 24
$-860.0K
$-9.6M
Q1 24
$-4.2M
$-2.5M
Operating Margin
IRWD
IRWD
XPOF
XPOF
Q4 25
14.3%
-9.9%
Q3 25
61.8%
4.5%
Q2 25
53.2%
19.5%
Q1 25
-70.7%
12.6%
Q4 24
34.8%
-62.4%
Q3 24
28.0%
-8.2%
Q2 24
26.5%
-4.0%
Q1 24
14.7%
10.0%
Net Margin
IRWD
IRWD
XPOF
XPOF
Q4 25
-4.8%
-39.6%
Q3 25
32.8%
-6.2%
Q2 25
27.7%
1.3%
Q1 25
-90.9%
-2.5%
Q4 24
2.5%
-52.3%
Q3 24
4.0%
-15.1%
Q2 24
-0.9%
-12.4%
Q1 24
-5.6%
-3.1%
EPS (diluted)
IRWD
IRWD
XPOF
XPOF
Q4 25
$0.01
$-1.18
Q3 25
$0.23
$-0.18
Q2 25
$0.14
$-0.01
Q1 25
$-0.23
$-0.10
Q4 24
$0.03
$-1.39
Q3 24
$0.02
$-0.29
Q2 24
$-0.01
$-0.30
Q1 24
$-0.03
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
XPOF
XPOF
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$525.0M
Stockholders' EquityBook value
$-261.8M
$-269.1M
Total Assets
$396.9M
$345.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
XPOF
XPOF
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
IRWD
IRWD
XPOF
XPOF
Q4 25
$525.0M
Q3 25
$199.5M
$376.4M
Q2 25
$199.3M
$377.8M
Q1 25
$199.2M
$379.1M
Q4 24
$199.0M
$352.4M
Q3 24
$198.8M
$353.8M
Q2 24
$198.6M
$330.1M
Q1 24
$398.3M
$331.4M
Stockholders' Equity
IRWD
IRWD
XPOF
XPOF
Q4 25
$-261.8M
$-269.1M
Q3 25
$-264.2M
$-230.4M
Q2 25
$-308.2M
$-225.0M
Q1 25
$-334.1M
$-225.2M
Q4 24
$-301.3M
$-216.6M
Q3 24
$-311.3M
$-155.7M
Q2 24
$-321.7M
$-151.9M
Q1 24
$-330.5M
$-144.4M
Total Assets
IRWD
IRWD
XPOF
XPOF
Q4 25
$396.9M
$345.6M
Q3 25
$396.1M
$355.3M
Q2 25
$342.9M
$399.8M
Q1 25
$327.2M
$412.4M
Q4 24
$350.9M
$403.4M
Q3 24
$389.5M
$472.2M
Q2 24
$395.6M
$475.2M
Q1 24
$438.8M
$508.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
XPOF
XPOF
Operating Cash FlowLast quarter
$74.6M
$10.7M
Free Cash FlowOCF − Capex
$74.6M
$10.2M
FCF MarginFCF / Revenue
156.3%
12.3%
Capex IntensityCapex / Revenue
0.0%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
XPOF
XPOF
Q4 25
$74.6M
$10.7M
Q3 25
$47.6M
$9.3M
Q2 25
$-15.1M
$2.5M
Q1 25
$20.0M
$5.8M
Q4 24
$15.2M
$776.0K
Q3 24
$9.9M
$5.2M
Q2 24
$33.5M
$3.0M
Q1 24
$45.0M
$2.7M
Free Cash Flow
IRWD
IRWD
XPOF
XPOF
Q4 25
$74.6M
$10.2M
Q3 25
$47.6M
$8.2M
Q2 25
$-15.1M
$996.0K
Q1 25
$19.9M
$5.4M
Q4 24
$674.0K
Q3 24
$9.9M
$3.4M
Q2 24
$33.4M
$872.0K
Q1 24
$44.9M
$1.8M
FCF Margin
IRWD
IRWD
XPOF
XPOF
Q4 25
156.3%
12.3%
Q3 25
39.0%
10.4%
Q2 25
-17.7%
1.3%
Q1 25
48.4%
7.0%
Q4 24
0.8%
Q3 24
10.8%
4.2%
Q2 24
35.4%
1.1%
Q1 24
60.0%
2.3%
Capex Intensity
IRWD
IRWD
XPOF
XPOF
Q4 25
0.0%
0.6%
Q3 25
0.0%
1.4%
Q2 25
0.0%
2.0%
Q1 25
0.1%
0.6%
Q4 24
0.0%
0.1%
Q3 24
0.0%
2.3%
Q2 24
0.1%
2.8%
Q1 24
0.1%
1.1%
Cash Conversion
IRWD
IRWD
XPOF
XPOF
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
2.60×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

XPOF
XPOF

Franchise$51.5M62%
Products$9.7M12%
Franchise Marketing Fund Revenue$8.9M11%
Service Other$8.3M10%
Spartan Fitness$4.5M5%

Related Comparisons